DIABETES DEVICES AND DRUGS MARKET ANALYSIS
Global diabetes devices and drugs market is estimated to be valued at US$ 158.4 billion in 2023 and is expected to exhibit a CAGR of 10% during the forecast period (2023-2030). Technological advancements in diabetes management devices is expected to be a key driver for market growth over the forecast period. Moreover, the increasing prevalence of diabetes and consequent rise in the adoption of insulin delivery devices is expected to further boost the global diabetes devices and drugs market growth
Figure 1. Global Diabetes Devices And Drugs Market Share (%), by Category, 2023
Global Diabetes Devices And Drugs Market- Driver
Increasing approvals and product launches of novel diagnostic and therapeutic products
In response to the increasing diabetic population, manufacturers are constantly putting efforts towards advancing the product technology making them more accessible. Increasing product approvals and launches is expected to be a key driver for the global diabetes devices and drugs market growth. For instance, in December 2022, Dexcom, Inc., a company that develops, manufactures, produces, and distributes continuous glucose monitoring systems for diabetes management, announced that its next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System has received the U.S. Food and Drug Administration (FDA) clearance for people with both Type1 and Type 2 diabetes that are aged two years and above.
Figure 2. Global Diabetes Devices And Drugs Market Share (%), by Region, 2023
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
